Medicalgorithmics (FRA:B8E) PEG Ratio: N/A (As of Jul. 02, 2026)


FRA:B8E Medicalgorithmics SA FRA:B8E
72 GF Score
Price €5.94
GF Value €6.00
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Medicalgorithmics's PE Ratio without NRI is 0.00. Medicalgorithmics's 5-Year EBITDA growth rate is 0.00%. Therefore, Medicalgorithmics's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Medicalgorithmics's PEG Ratio or its related term are showing as below:


During the past 13 years, Medicalgorithmics's highest PEG Ratio was 1.01. The lowest was 0.17. And the median was 0.37.


FRA:B8E's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.03
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Medicalgorithmics  (FRA:B8E) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Medicalgorithmics PEG Ratio Related Terms


Medicalgorithmics PEG Ratio Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics PEG Ratio Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:B8E vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, Medicalgorithmics's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicalgorithmics PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Medicalgorithmics's PEG Ratio falls into.


FRA:B8E
72GF Score
Medicalgorithmics SA FRA:B8E
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicalgorithmics PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Medicalgorithmics's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued. The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.

Key valuation signals for FRA:B8E:

  • PEG Ratio: N/A
  • GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for FRA:B8E

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.94
Price
€6.00
GF Value